T cell proliferation-augmenting activities of the gene 3 protein derived from a phage library clone with CD80-binding activity

Journal of Immunology

Volumn 161, Issue 12, 1998, Pages 6622-6628

  Fukumoto, Takahiro ^a   Torigoe, Naohiko ^a   Ito, Yuji ^a   Kajiwara, Yasuhiro ^a   Sugimura, Kazuhisa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; GENE PRODUCT;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; BACTERIOPHAGE; CONTROLLED STUDY; GENE INSERTION; GENE LIBRARY; IMMUNOPOTENTIATION; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; CLONING, MOLECULAR; CRICETINAE; DNA-BINDING PROTEINS; GENE LIBRARY; HUMANS; IMMUNOCONJUGATES; INOVIRUS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; VIRAL FUSION PROTEINS;

EID: 0032534731     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Linsley, P. S., W. Brady, L. Grosmaire, A. Aruffo, N. K. Damle, and J. A. Ledbetter. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:721.
2. Walunas, T. L., D. J. Lenschow, C. Y. Bakker, P. S. Linsley, G. J. Freeman, J. M. Green, C. B. Thompson, and J. A. Bluestone. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405.
3. Linsley, P. S., W. Brady, M. Urnes, L. S. Grosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
4. Azuma, M., D. Ito, H. Yagita, K. Okumura, J. H. Phillips, L. L. Lanie, and C. Somoza, 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76.
5. Freeman, G. J., J. G. Gribben, V. A. Boussiotis, J. W. Ng, V. A. Restivo Jr, L. A. Lombard, G. S. Gray, and L. M. Nadler. 1993. Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262:909.
6. Linsley, P. S., J. L. Greene, W. Brady, J. Bajorath, J. A. Ledbetter, and R. Peach. 1994. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1:793.
7. Bluestone, J. A. 1997. Is CTLA-4 a master switch for peripheral T cell tolerance? J. Immunol. 158:1989.
8. Thompson, C. B., and J. P. Allison. 1997. The emerging role of CTLA-4 as an immune attenuator. Immunity 7:445.
9. Fargeas, C. A., A. Truneh, M. Reddy, M. Hurle, R. Sweet, and R. P. Sekaly. 1995. Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4. J. Exp. Med. 182:667.
10. Guo, Y., Y. Wu, M. Zhao, X. P. Kong, and Y. Liu. 1995. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain. J. Exp. Med. 181:1345.
11. Kariv, I., A. Truneh and R. W. Sweet. 1996. Analysis of the site of interaction of CD28 with its counter-receptors CD80 and CD86 and correlation with function. J. Immunol. 157:29.
12. Peach, R. J., J. Bajorath, W. Brady, G. Leytze, J. Greene, J. Naemura, and P. S. Linsley. 1994. Complementarity determining region 1 (CDR1)-and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. J. Exp. Med. 180:2049.
13. Peach, R. J., J. Bajorath, J. Naemura, G. Leytze, J. Greene, A. Aruffo, and P. S. Linsley. 1995. Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28. J. Biol. Chem. 270:21181.
14. Truneh, A., M. Reddy, P. Ryan, S. D. Lyn, C. Eichman, D. Couez, M. R. Hurle, R. P. Sekaly, D. Olive, and R. Sweet. 1996. Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis. Mol. Immunol. 33:321.
15. Morton, P. A., X. T. Fu, J. A. Stewart, K. S. Giacoletto, S. L. White, C. E. Leysath, R. J. Evans, J. J. Shieh, and R. W. Karr. 1996. Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2). J. Immunol. 156:1047.
16. Rennert, P., K. Furlong, C. Jellis, E. Greenfield, G. J. Freeman, Y. Ueda, B. Levine, J. H. June, and G. S. Gray. 1997. The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion. Int. Immunol. 9:805.
17. Metzler, W. J., J. Bajorath, W. Fenderson, S. Y. Shaw, K. L. Constantine, J. Naemura, G. Leytze, R. J. Peach, T. B. Lavoie, L. Mueller, and P. S. Linsley. 1997. Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28. Nat. Struct. Biol. 4:527.
18. Walunas, T. L., C. Y. Bakker, and J. A. Bluestone. 1996. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183:2541.
19. Krummel, M. F., T. J. Sullivan, and J. P. Allison. 1996. Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo. Int. Immunol. 8:519.
20. Krummel, M. F., and J. P. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459.
21. Waterhouse, P., J. M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K. P. Lee, C. B. Thompson, H. Griesser, and T. W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270: 985.
22. Yayon, A., D. Aviezer, M. Safran, J. L. Gross, Y. Heldman, S. Cabilly, D. Givol, and E. Katchalski-Katzir. 1993. Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library. Proc. Natl. Acad. Sci. USA 90:10643.
23. Ellis, J. H., M. N. Burden, D. V. Vinogradov, C. Linge, and J. S. Crowe. 1996. Interactions of CD80 and CD86 with CD28 and CTLA4. J. Immunol. 56:2700.
24. Fukumoto, T., N. Torigoe, S. Kawabata, M. Murakami, T. Uede, T. Nishi, Y. Ito, and K. Sugimura 1998. Peptide mimics of the CTLA4-binding domain stimulate T-cell proliferation. Nat. Biotechnol. 16:267.
25. Wrighton, N. C., F. X. Farrell, R. Chang, A. K. Kashyap, F. P. Barbone, L. S. Mulcahy, D. L. Johnson, R. W. Barrett, L. K. Jolliffe, and W. J. Dower. 1996. Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273:458.
26. Barchan, D., M. Balass, M. C. Souroujon, E. Katchalski-Katzir, and S. Fuchs. 1995. Identification of epitopes within a highly immunogenic region of acetylcholine receptor by a phage epitope library. J. Immunol. 155:4264.
27. Parmley, S. F., and G. P. Smith. 1988. Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene 73:305.
28. Welply, J. K., C. N. Steininger, M. Caparon, M. L. Michener, S. C. Howard, L. E. Pegg, D. M. Meyer, P. A. De Ciechi, C. S. Devine, and G. F. Casperson. 1996. A peptide isolated by phage display binds to ICAM-1 and inhibits binding to LFA-1. Proteins 26:262.
29. Fukumoto, T., N. Torigoe, S. Kawabata, Y. Kaneko, M. Murakami, T. Uede, T. Nishi, G. Yamada, and K. Sugimura. 1997. Ligand-binding activity of phage clones captured by anti-receptor antibody from phage display library. Pept. Chem. 1996:313.
30. c-src identified using a random 15-amino-acid peptide library. FEBS Lett. 399:237.
31. Kremser, A., and I. Rasched. 1994. The adsorption protein of filamentous phage fd: assignment of its disulfide bridges and identification of the domain incorporated in the coat. Biochemistry 33:13954.
32. Greene, J. L., G. M. Leytze, J. Emswiler, R. Peach, J. Bajorath, W. Cosand, and P. S. Linsley. 1997. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J. Biol. Chem. 271:26762-71.
33. Anton van der Merwe, P., D. L. Bodian, S. Daenke, P. Linsley, and S. J. Davis. 1997. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/ CD86 regulate T cell costimulatory interactions. J. Exp. Med. 185:393.
34. Bachmann, M. F., and R. M. Zinkemagel. 1996. The influence of virus structure on antibody responses and virus serotype formation. Immunol. Today 17:553.